Aims: To determine the predictive value of fetal pulse oximetry (FPO) for the development of fetal acidosis in cases of non-reassuring fetal heart rate (FHR). Methods: In a prospective observational study, pulse oximetry monitoring was examined in cases of non-reassuring FHR during singleton cephalic delivery at 36-42 weeks' gestation. The study examined whether fetal arterial oxygen saturation (FSpO 2 ) values -30% for at least 10 min during the last 60 min before delivery increase the risk of fetal acidosis. The predictive reliability of this algorithm and the correlation to fetal acidosis wumbilical artery pH (UApH) -7.15x were analyzed. Results: We included 101 patients with non-reassuring FHR during delivery. The incidence of fetal acidosis was significantly higher when FSpO 2 values -30% were recorded for at least 10 min (Ps0.0). An UApH -7.15 was reliably excluded with a negative predictive value of 98.7% and detected with a sensitivity of 92.9%. Conclusions: A low pulse oximetry oxygen saturation -30% for at least 10 min correlates highly with fetal acidosis in cases of non-reassuring FHR. FPO reliably excludes moderate to advanced acidosis and can reduce the frequency of fetal blood analysis (FBA) in cases of non-reassuring cardiotocography (CTG).
Introduction
The aim of intrapartum electronic fetal monitoring is to detect high-risk conditions early enough to prevent damage to the fetus. However, cardiotocography (CTG) with nonreassuring fetal heart rate (FHR) patterns very often corre- spond to physiological changes w13x. With high sensitivity but low specificity of the monitoring method, false-positive CTG results would lead to an increase in unjustified operative deliveries w1, 6, 18x. The high false-positive rate of intrapartum CTG can be reduced by performing fetal blood analysis (FBA). Combined intrapartum monitoring (CTG plus FBA) with determination of the fetal acid-base status achieves the necessary diagnostic reassurance in cases of non-reassuring FHR w5x. Investigations have demonstrated a reduction in hypoxia-related mortality w19x, neonatal convulsions w1x and avoidable operative deliveries when FBA is indicated w8x. The procedure has not gained general acceptance in many countries because it requires additional expertise, yields random results necessitating repeated fetal blood sampling, and is a complex and invasive method. There is an ongoing search for a complementary intrapartum monitoring method that adds valuable information like fetal pulse oximetry (FPO) oxygen saturation w4, 17x. Registered simultaneously with the CTG, FPO with good signal quality confirms FHR changes associated with fetal hypoxemia. The value of this monitoring procedure depends on its reliability in detecting or excluding fetal acidosis in cases of non-reassuring FHR. Simultaneous monitoring with FPO could have the advantage of reducing the need for complex FBA without increasing the risk of fetal damage due to undetected anoxic phases. Fetal arterial oxygen saturation (FSpO 2 ) measured by pulse oximetry has a critical threshold value of 30% according to experimental studies and clinical data obtained using the N-400 fetal pulse oximeter and the FS14B fetal sensor (Nellcor, Pleasanton, CA, USA) w12, 15x. Fetal acidosis may be expected if FSpO 2 remains below 30% for a longer period of time w6, 10, 16x. A major problem associated with FPO registration -the poor application stability and high signal loss of the now discontinued FS14 fetal sensor (Nellcor system) -has been overcome. The FetalSAT pulse oximeter (NONIN Medical Inc., Plymouth, MN, USA) records reliable FSpO 2 data in over 90% of the registered time period w9x. The third FPO system, OB Scientific (Germantown, WI, USA) uses a tongue-depressor-shaped sensor that is placed on the fetal body. Postductal FSpO 2 values obtained from this localization are lower than oxygen saturation measurements in cases of breech presentation w11x.
Using FPO as a complementary technique in combined intrapartum monitoring, this study examined whether the FSpO 2 threshold value of 30% determined for the N-400 pulse oximeter can also be used for the FetalSAT system to reliably detect or exclude the presence of fetal acidosis. Fetal hypoxemia was assumed at FSpO 2 values below 30% for at least 10 min during the last 60 min before delivery. Despite the different measuring systems and sensors, the significance of threshold value analysis for detecting or excluding fetal acidosis was tested at different times, first with the Nellcor system and then with the FetalSAT system.
Methods
A prospective observational study was performed to examine the value of intrapartum FPO in cases of non-reassuring CTG. It included women with a single fetus in cephalic presentation at 36-42 weeks' gestation and cervical dilatation G3 cm. FPO was used as a complementary technique in combined intrapartum monitoring. When FHR findings constituted an indication for FBA, the sensor was applied after obtaining informed consent from the mother. Continuous measurement was performed by appropriately trained obstetricians without blinding. values -30% were added to obtain the total duration during the last 60 min before delivery. The aim was to examine whether an UApH of -7.15 is significantly associated with FSpO 2 values -30% for at least 10 min during the last 60 min before delivery and to determine the probability with which it may be predicted or excluded. For this purpose, FSpO 2 values of -30% over a period of G10 min were examined for their sensitivity and specificity as well as their negative and positive predictive value. The data were first assessed separately for the groups monitored with the Nellcor and the FetalSAT system and then for the total group. Statistical significance was calculated by Fisher's exact test and by Spearman correlation.
Results
Assessment of registered values revealed adequate signal processing with the Nellcor N-400 pulse oximeter in 49 of 65 cases but reliable signal acquisition with the FetalSAT system in over 90% of the recording time. Intrapartum monitoring was assessed in all but two cases, which were excluded for too short a recording time (52 of 54). The incidence of cesarean delivery for dystocia (NONIN group 7.8%) doubled in the Nellcor group (16.2%). In cases with a non-reassuring CTG, the incidence of fetal acidosis (UApH -7.15) was significantly higher for a G10-min period of FSpO 2 values -30% than for periods of -10 min during the last 60 min before delivery. This could be demonstrated in the single groups (Nellcor system: Ps0.0002, FetalSAT system: Ps0.0) as well as in the overall assessment (Ps0.0). A scatter plot shows the UApH values and the duration of FSpO 2 values -30% in 101 neonates (Figure 1 ). The FSpO 2 values -30% during the last 60 min before delivery correlate significantly with the UApH values at the 0.01 level.
In the group monitored with the Nellcor system (Table 1) , UApH values -7.15 were determined in 7 of 49 neonates. In cases with FSpO 2 values -30% for -10 min, an intrapartum UApH -7.15 was seen in only one neonate with a diabetic mother (negative predictive value: 97.4%). In six neonates with UApH values -7.15, the FSpO 2 values -30% added up to G10 min during the last hour of delivery (sensitivity: 85.7%). Altogether 11 of 49 neonates had FSpO 2 values -30% for at least 10 min during the last hour of delivery. The UApH value was G7.15 in five cases, and the result was thus false-positive (specificity: 88.1%). SpO 2 values -30% for G10 min during the last hour before delivery were found to have a positive predictive value of 54.6%.
In the FetalSAT group ( to a specificity of 87.4% and a positive predictive value of 54.2%.
Discussion
A number of clinical studies have examined the mean fetal oxygen saturation over a defined time period in comparison with the UApH or base excess. They demonstrated good correlation as well as independence w20x. Studies examining the FSpO 2 threshold value of 30% combined with an interval of at least 2 w2x or 10 min w6, 17x have shown an increase in adverse fetal events. Prospective randomized studies on the use of FPO for intrapartum fetal monitoring have been performed with the Nellcor N-400 pulse oximeter w3, 6, 7, 10x. The primary endpoints of the studies were the rate of operative deliveries for uncertain fetal status in cases with a nonreassuring CTG or low FSpO 2 and the overall rate of operative deliveries. The overall rate of operative deliveries did not differ between groups monitored with and without FPO, whereas the rate of operative deliveries for uncertain fetal status was significantly lower when FPO was used w6, 7, 10x. The controlled multicenter study by Garite et al. w7x achieved a 50% reduction in the rate of cesarean sections for non-reassuring CTG findings in the group with FPO, though the overall cesarean section rate remained constant. In cases of operative intervention for uncertain fetal status, the FPO group was found to have higher sensitivity and specificity for the secondary endpoints of fetal monitoring -metabolic acidosis and resuscitation of neonates w7x. Acquisition of pulse oximetry data did not reduce the rate of cesarean section or fetal acidosis in the largest controlled study conducted by Bloom et al. w3x and comprised more than 5000 monitored deliveries. The rate of cesarean section for dystocia was as high as in the study by East et al. w6x when using the Nellcor sensor. In our study the rate for cesarean section for dystocia, was doubled in the Nellcor group compared to the NONIN group. Different durations of FSpO 2 values of -30% were used to define uncertain fetal status with low oxygen saturation in the studies mentioned. When assessing low fetal oxygen saturation by FSpO 2 values -30%, some studies applied a duration of at least 10 min w6, 10x rather than of 2 min or of an entire interval between contractions applied by others w3, 7x. With this definition, high rates of low FSpO 2 were found even in cases with normal FHR patterns w3x. The FOREMOST study demonstrated a significant reduction of operative interventions in the FPO group without difference in neonatal outcome w6x. In one study, FBA was routinely applied for combined intrapartum monitoring in cases with non-reassuring FHR patterns. The use of FPO in such cases reduced the operative delivery rate and the frequency of FBA by 50% w10x. Seelbach-Göbel and Riedl w16x demonstrated that, in cases of non-reassuring CTG, the threshold value analysis (FSpO 2 F30% for at least 10 min) was able to detect (sensitivity) or exclude (negative predictive value) an UApH below 7.1 with 100% reliability. On repetition of an FBA, a significant pH decrease of 0.1 pH units could also be excluded with high probability (negative predictive value of 98%).
In the present study, the FPO recorded simultaneously with the CTG was not included in obstetrical decisions. In cases of non-reassuring CTG, FBA was used as a complementary technique to the diagnostic tests of fetal status, and delivery was operatively terminated in cases with fetal pH values -7.20. Limiting the analysis of FSpO 2 values -30% to the last 60 min before delivery takes into account the experience that low FSpO 2 values as well as non-reassuring FHR patterns in earlier phases of labor can be corrected after improvement of the fetal oxygen supply and normalization of the intrapartum monitoring values. FPO for intrapartum fetal assessment has been restricted to the last 30 or 10 min before delivery in other studies as well w10, 14x. Fetal acidosis was defined as an UApH -7.15 in accordance with the study by Dildy et al. w4x , in which UApH values only differ at -or G7.13 with an umbilical artery oxygen saturation cut-off of 30%.
Despite differences in the sensor wavelengths and measuring systems (Nellcor-FS 14B 735 and 890 nm/FetalSATDualSens 661 and 905 nm), analysis of the FSpO 2 values for both fetal pulse oximeters showed that low fetal oxygen saturation -FSpO 2 -30% G10 min during the last 60 min before delivery -was significantly associated with an increased incidence of fetal acidosis (UApH -7.15). Saturation monitoring with the FetalSAT system also disclosed a time-dependent rise of fetal acidosis in conjunction with values below the FSpO 2 threshold of 30%. In the total group, FSpO 2 values G30% or below 30% for a total duration of -10 min, respectively, excluded fetal acidosis (UApH -7.15) with 98.7% probability (negative predictive value) and detected it in 92.9% (sensitivity). With a specificity of 87.4% and a positive predictive value of 54.2%, sustained low FSpO 2 values alone do not justify operative delivery. Here, FBA is required for promptly determine fetal status if the CTG does not suggest an acute fetal risk. The reliability of pulse oximetry monitoring is influenced by signal loss as well as by individual fetal factors, such as fetal infection, maternal diabetes (quick development of metabolic acidosis) and fetal anemia (inadequate oxygen supply despite normal FSpO 2 values). To avoid false assessments, an FBA to determine the initial fetal acid-base status is recommended at the start of simultaneous pulse oximetry monitoring in cases of non-reassuring CTG w17x. Saturation measurements must be constantly checked for plausibility, and, in case of doubt, FBA should be repeated even in the presence of normal FSpO 2 values.
